LEVETIRACETAM EG 100 mg/ml, oral solution bottle, 300 ml
Active ingredients: (S)-etiracetam
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 300 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LEVETIRACETAM EG 100 mg/mL, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon en verre brun avec fermeture de sécurité enfant de 300 mL avec seringue doseuse de 10 mL polypropylène polyéthylène
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Jun 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67390276CIP73015846CIP133400930158463Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVÉTIRACÉTAMsolution | 100 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.